Jitendra Singh Kushwaha

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 438 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 365 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)

Chandramani Singh, Savita Verma, Prabhakar Reddy et al. · npj Vaccines · 2023 · 83 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · medRxiv · 2020 · 38 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants

Krishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy et al. · Scientific Reports · 2022 · 34 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17